Learn More about how Our Insights are Impacting the Future of Biopharma
Join in the conversation and learn more through this collection of relevant views, perspectives, and insights on issues that affect the next generation of clinical trials and commercial strategies.
The Relentless Pursuit of Answers: Our Family’s Rare Disease Journey
Jeff Hoffman, the Chief Development Officer/Partner of Havas Health and founder of HVH Patient Precision Analytics, shares his personal experience as the parent of a child with a rare disease.
Jeff’s journey offered insights that led to the formation of HVH Patient Precision Analytics. Read More >
Next Generation Commercial Strategy
Jeff Ceitlin, the Chief Commercial Officer of HVH Patient Precision Analytics discusses how new opportunities to accelerate diagnoses through predictive modeling will change how companies market much-needed therapies. Read More >
Finding UNDIAGNOSED Patients, the new frontier In Market expansion
HVH Patient Precision Analytics offers a real-world, evidence-based approach that helped a biopharma company expand the market for its ultra-orphan disease therapy. See Case Study >
HVH Announces Patient-Finding Technology
Finding aberrations and behavior patterns by sifting through big data is the core of our unique offering and how we are able to connect hard-to-diagnose patients with treatments and cures. Read Press Release >
HVH’s Methodology Validated in Peer Reviewed Journal
HVH’s predictive analysis was proven to find rare disease patients in a large and complex database that revealed insights into optimizing outcomes and costs when analyzed using our methodology. Read More >